Alnylam achieved profitability for…
Alnylam achieved profitability for the first time in its history [...]
Just months after laying off a…
Just months after laying off a quarter of its workforce [...]
BridgeBio is hoping that…
BridgeBio is hoping that infigratinib will get another shot at [...]
U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine
The F.D.A.’s refusal to examine the company’s mRNA shot drew [...]
For all of the groundbreaking…
For all of the groundbreaking advancements in cancer treatment over [...]
OpenAI’s Biggest Challenge Is Turning Its A.I. Into a Cash Machine
The maker of ChatGPT hopes to triple its revenue in [...]
For months now, all signs have…
For months now, all signs have pointed to a looming, [...]
Madrigal Pharmaceuticals is…
Madrigal Pharmaceuticals is continuing to splash the cash this year [...]
A phase 2 asthma study of Upstream…
A phase 2 asthma study of Upstream Bio’s TSLP receptor [...]
I Just Returned From China. We Are Not Winning.
If we are going to be competitive with China, we [...]